Although it occurs recurrently in other neoplasms, such as AML and high-grade gliomas, IDH-2 mutations, when present in MTCL, are practically exclusive to AITL and are usually restricted to the arginine residue 172 (R172K and R172S) (66, 69). Here, IDH2 is linked to neoplasm.